Study looks at why pancreatic cancer drugs fail

Tuesday 26 May 2009

Scientists have described a mechanism that appears to explain why patients with pancreatic cancer can be resistant to the chemotherapy drug, gemcitabine. Their findings appear in the May 2009 issue of Science.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom